Evidence map›Paper›PMID 32382760›Full record

ArticleJapanese journal of clinical oncology2020

Erratum to: Outcome of maintenance systemic chemotherapy with drug-free interval for metastatic urothelial carcinoma.

T Abe, K Minami, T Harabayashi, A Sazawa, H Chiba, H Kikuchi, H Miyata, R Matsumoto, T Osawa, S Maruyama and 9 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Japanese journal of clinical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

T AbeDepartment of Urology, Hokkaido University Hospital, Sapporo, Japan.
K MinamiHokkaido Urothelial Cancer Research Group, Sapporo, Japan.
T HarabayashiHokkaido Urothelial Cancer Research Group, Sapporo, Japan.
A SazawaHokkaido Urothelial Cancer Research Group, Sapporo, Japan.
H ChibaHokkaido Urothelial Cancer Research Group, Sapporo, Japan.
H KikuchiDepartment of Urology, Hokkaido University Hospital, Sapporo, Japan.
H MiyataDepartment of Urology, Hokkaido University Hospital, Sapporo, Japan.
R MatsumotoDepartment of Urology, Hokkaido University Hospital, Sapporo, Japan.
T OsawaDepartment of Urology, Hokkaido University Hospital, Sapporo, Japan.
S MaruyamaDepartment of Urology, Hokkaido University Hospital, Sapporo, Japan.
J IshizakiIshizakiHokkaido Urothelial Cancer Research Group, Sapporo, Japan.
T MochizukiHokkaido Urothelial Cancer Research Group, Sapporo, Japan.
S ChibaHokkaido Urothelial Cancer Research Group, Sapporo, Japan.
T AkinoHokkaido Urothelial Cancer Research Group, Sapporo, Japan.
M MurakumoHokkaido Urothelial Cancer Research Group, Sapporo, Japan.
N MiyajimaHokkaido Urothelial Cancer Research Group, Sapporo, Japan.
K TsuchiyaHokkaido Urothelial Cancer Research Group, Sapporo, Japan.
S MuraiDepartment of Urology, Hokkaido University Hospital, Sapporo, Japan.
N ShinoharaDepartment of Urology, Hokkaido University Hospital, Sapporo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32382760
PMCPMC7284546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.